• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mA RNA 去甲基酶 FTO 通过抑制 TFPI-2 促进胰腺癌细胞的生长、迁移和侵袭。

mA RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2.

机构信息

Department of Pancreatic Surgery, Renmin Hospital of Wuhan University, Wuhan Hubei Province, China.

The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-most) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan Hubei Province, China.

出版信息

Epigenetics. 2022 Dec;17(12):1738-1752. doi: 10.1080/15592294.2022.2061117. Epub 2022 Apr 11.

DOI:10.1080/15592294.2022.2061117
PMID:35404184
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9621031/
Abstract

Pancreatic cancer (PC) is one of the most fatal cancers with a very poor prognosis. Here, we found that N-methyladenosine (mA) RNA demethylase fat mass and obesity-related protein (FTO) promote the growth, migration and invasion of PC. FTO expression level is increased in human PC and is associated with poor prognosis of PC patients. Knockdown of FTO increases mA methylation of TFPI-2 mRNA in PC cells, thereby increasing mRNA stability via the mA reader YTHDF1, resulting in up-regulation of TFPI-2 expression, and inhibits PC proliferation, colony formation, sphere formation, migration and invasion , as well as tumour growth . Rescue assay further confirms that FTO facilitates cancer progression by reducing the expression of TFPI-2. Mechanistically, FTO promotes the progression of PC at least partially through reducing mA/YTHDF1 mediated TFPI-2 mRNA stability. Our findings reveal that FTO, as an mA demethylase, plays a critical role in promoting PC growth, migration and invasion, suggesting that FTO may be a potential therapeutic target for treating PC.

摘要

胰腺癌(PC)是预后最差的致命癌症之一。在这里,我们发现 N6-甲基腺苷(m6A)RNA 去甲基酶肥胖相关蛋白(FTO)促进 PC 的生长、迁移和侵袭。FTO 在人 PC 中的表达水平增加,与 PC 患者的预后不良相关。FTO 敲低可增加 PC 细胞中 TFPI-2 mRNA 的 m6A 甲基化,从而通过 m6A 阅读器 YTHDF1 增加 mRNA 稳定性,导致 TFPI-2 表达上调,抑制 PC 增殖、集落形成、球体形成、迁移和侵袭,以及肿瘤生长。挽救实验进一步证实,FTO 通过降低 TFPI-2 的表达促进癌症进展。从机制上讲,FTO 至少部分通过降低 m6A/YTHDF1 介导的 TFPI-2 mRNA 稳定性促进 PC 的进展。我们的研究结果表明,FTO 作为一种 m6A 去甲基酶,在促进 PC 生长、迁移和侵袭中发挥关键作用,提示 FTO 可能是治疗 PC 的潜在治疗靶点。

相似文献

1
mA RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2.mA RNA 去甲基酶 FTO 通过抑制 TFPI-2 促进胰腺癌细胞的生长、迁移和侵袭。
Epigenetics. 2022 Dec;17(12):1738-1752. doi: 10.1080/15592294.2022.2061117. Epub 2022 Apr 11.
2
N -methyladenosine RNA demethylase FTO regulates extracellular matrix-related genes and promotes pancreatic cancer cell migration and invasion.N -甲基腺苷 RNA 去甲基酶 FTO 调控细胞外基质相关基因并促进胰腺癌细胞迁移和侵袭。
Cancer Med. 2023 Feb;12(3):3731-3743. doi: 10.1002/cam4.5054. Epub 2022 Jul 25.
3
RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an mA-YTHDF2-dependent manner.RNA N6-甲基腺嘌呤去甲基酶 FTO 通过诱导 mA-YTHDF2 依赖性 PDGFC 的自分泌活性促进胰腺癌进展。
Oncogene. 2022 May;41(20):2860-2872. doi: 10.1038/s41388-022-02306-w. Epub 2022 Apr 14.
4
FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.FTO 通过依赖 m6A 的方式促进膀胱癌的增殖和迁移,增强 STAT3 mRNA 的稳定性。
Epigenetics. 2023 Dec;18(1):2242688. doi: 10.1080/15592294.2023.2242688.
5
FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.FTO 通过依赖于 N6-甲基腺苷的方式降低 APOE mRNA 的稳定性,从而抑制甲状腺乳头状癌细胞的糖酵解和生长。
J Exp Clin Cancer Res. 2022 Jan 28;41(1):42. doi: 10.1186/s13046-022-02254-z.
6
mA demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.mA 去甲基酶 FTO 通过调节 MZF1 表达促进肺鳞癌肿瘤进展。
Biochem Biophys Res Commun. 2018 Aug 25;502(4):456-464. doi: 10.1016/j.bbrc.2018.05.175. Epub 2018 Jun 2.
7
FTO/IGF2BP2-mediated N6 methyladenosine modification in invasion and metastasis of thyroid carcinoma via CDH12.FTO/IGF2BP2 介导的 N6 甲基腺苷修饰通过 CDH12 促进甲状腺癌的侵袭和转移。
Cell Death Dis. 2024 Oct 8;15(10):733. doi: 10.1038/s41419-024-07097-4.
8
FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.FTO 通过调节 BMP4/Hippo/YAP1/TAZ 通路促进宫颈癌细胞增殖、集落形成、迁移和侵袭。
Exp Cell Res. 2023 Jun 1;427(1):113585. doi: 10.1016/j.yexcr.2023.113585. Epub 2023 Apr 6.
9
The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.m6A 去甲基酶 FTO 通过调节 USP7 mRNA 的 m6A 水平促进肺癌细胞的生长。
Biochem Biophys Res Commun. 2019 May 7;512(3):479-485. doi: 10.1016/j.bbrc.2019.03.093. Epub 2019 Mar 21.
10
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.RNA N6-甲基腺嘌呤去甲基化酶 FTO 通过抑制 BNIP3 促进乳腺癌进展。
Mol Cancer. 2019 Mar 28;18(1):46. doi: 10.1186/s12943-019-1004-4.

引用本文的文献

1
Tissue Factor Pathway Inhibitor 2 Enhances Hepatocellular Carcinoma Chemosensitivity by Activating CCAR2-GADD45A-Mediated DNA Damage Repair.组织因子途径抑制因子2通过激活CCAR2-GADD45A介导的DNA损伤修复增强肝细胞癌的化疗敏感性。
Int J Biol Sci. 2025 Jul 11;21(10):4629-4646. doi: 10.7150/ijbs.111142. eCollection 2025.
2
Role of m6A RNA methylation regulators in pancreatic cancer: interactions and potential implications.m6A RNA甲基化调节剂在胰腺癌中的作用:相互作用及潜在影响
Cancer Cell Int. 2025 Aug 4;25(1):292. doi: 10.1186/s12935-025-03922-8.
3
Recent Findings in N6-Methyladenosine Modification and Significance in Pancreatic Cancer.N6-甲基腺嘌呤修饰的最新研究发现及其在胰腺癌中的意义
Cancer Med. 2025 Jun;14(11):e70934. doi: 10.1002/cam4.70934.
4
Role and mechanisms of m6A demethylases in digestive system tumors.m6A去甲基化酶在消化系统肿瘤中的作用及机制
Am J Cancer Res. 2025 Apr 15;15(4):1436-1460. doi: 10.62347/XMAF1290. eCollection 2025.
5
Reassessing the Role of Tissue Factor Pathway Inhibitor 2 in Neoplastic and Non-Neoplastic Lesions.重新评估组织因子途径抑制物2在肿瘤性和非肿瘤性病变中的作用
Cancers (Basel). 2025 Apr 25;17(9):1447. doi: 10.3390/cancers17091447.
6
Exploring diagnostic m6A regulators in primary open-angle glaucoma: insight from gene signature and possible mechanisms by which key genes function.探索原发性开角型青光眼中的诊断性m6A调控因子:来自基因特征的见解以及关键基因发挥作用的可能机制
BMC Med Genomics. 2025 Mar 24;18(1):57. doi: 10.1186/s12920-025-02123-6.
7
Regulation of mA (N-Methyladenosine) methylation modifiers in solid cancers.固体瘤中 mA(N6-甲基腺苷)甲基化修饰物的调控。
Funct Integr Genomics. 2024 Oct 23;24(6):193. doi: 10.1007/s10142-024-01467-z.
8
Tissue factor pathway inhibitor-2 (TFPI-2)-an underappreciated partaker in cancer and metastasis.组织因子途径抑制剂-2(TFPI-2)——在癌症和转移中被低估的参与者。
Cancer Metastasis Rev. 2024 Dec;43(4):1185-1204. doi: 10.1007/s10555-024-10205-7. Epub 2024 Aug 17.
9
FTO-mediated autophagy inhibition promotes non-small cell lung cancer progression by reducing the stability of SESN2 mRNA.FTO介导的自噬抑制通过降低SESN2 mRNA的稳定性促进非小细胞肺癌进展。
Heliyon. 2024 Mar 7;10(5):e27571. doi: 10.1016/j.heliyon.2024.e27571. eCollection 2024 Mar 15.
10
KCTD15 acts as an anti-tumor factor in colorectal cancer cells downstream of the demethylase FTO and the m6A reader YTHDF2.KCTD15 在去甲基化酶 FTO 和 m6A 阅读器 YTHDF2 的下游作为结直肠癌细胞中的抗肿瘤因子发挥作用。
Commun Biol. 2024 Mar 4;7(1):262. doi: 10.1038/s42003-024-05880-9.

本文引用的文献

1
Association of subcellular localization of TEAD transcription factors with outcome and progression in pancreatic ductal adenocarcinoma.TEAD转录因子的亚细胞定位与胰腺导管腺癌的预后及进展的相关性
Pancreatology. 2021 Jan;21(1):170-179. doi: 10.1016/j.pan.2020.12.003. Epub 2020 Dec 8.
2
Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.胃肠道的表观遗传学改变:癌症生物标志物的当前和新兴用途。
Gastroenterology. 2021 Feb;160(3):690-709. doi: 10.1053/j.gastro.2020.09.058. Epub 2020 Dec 3.
3
MicroRNA-23a acts as an oncogene in pancreatic carcinoma by targeting TFPI-2.微小RNA-23a通过靶向组织因子途径抑制物-2(TFPI-2)在胰腺癌中发挥癌基因作用。
Exp Ther Med. 2020 Nov;20(5):53. doi: 10.3892/etm.2020.9181. Epub 2020 Sep 4.
4
Fat mass and obesity-associated protein promotes the tumorigenesis and development of liver cancer.脂肪量与肥胖相关蛋白促进肝癌的发生与发展。
Oncol Lett. 2020 Aug;20(2):1409-1417. doi: 10.3892/ol.2020.11673. Epub 2020 May 25.
5
FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13.FTO 通过上调 MMP13 促进食管鳞癌细胞的增殖和迁移。
Exp Cell Res. 2020 Apr 1;389(1):111894. doi: 10.1016/j.yexcr.2020.111894. Epub 2020 Feb 6.
6
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
7
RNAInter in 2020: RNA interactome repository with increased coverage and annotation.2020 年的 RNAInter:具有更高覆盖率和注释的 RNA 相互作用组库。
Nucleic Acids Res. 2020 Jan 8;48(D1):D189-D197. doi: 10.1093/nar/gkz804.
8
mA Methylation of Precursor-miR-320/RUNX2 Controls Osteogenic Potential of Bone Marrow-Derived Mesenchymal Stem Cells.前体微RNA-320/Runx2的甲基化调控骨髓间充质干细胞的成骨潜能
Mol Ther Nucleic Acids. 2020 Mar 6;19:421-436. doi: 10.1016/j.omtn.2019.12.001. Epub 2019 Dec 12.
9
Functions of N6-methyladenosine and its role in cancer.N6-甲基腺苷的功能及其在癌症中的作用。
Mol Cancer. 2019 Dec 4;18(1):176. doi: 10.1186/s12943-019-1109-9.
10
m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation.m6A去甲基化酶FTO通过介导丙酮酸激酶M2(PKM2)去甲基化促进肝细胞癌的肿瘤发生。
Am J Transl Res. 2019 Sep 15;11(9):6084-6092. eCollection 2019.